HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritis.

AbstractOBJECTIVE:
Production of anti-citrullinated protein antibodies (ACPAs) is an important biomarker for rheumatoid arthritis (RA). We undertook this study to determine whether genetic factors (HLA-DRB1 alleles) are associated with extreme ACPA levels in individuals with ACPA-positive RA, and to ascertain whether there are any phenotypic characteristics associated with these subgroups of RA.
METHODS:
HLA-DRB1 allelic groups were genotyped in 1,073 ACPA-positive RA patients from the Swedish Epidemiological Investigation of Rheumatoid Arthritis study. We found that 283 patients (26.4%) had high ACPA levels (defined as >1,500 units/ml using the Euro-Diagnostica anti-CCP2 test), while the rest of the patients had moderate ACPA levels and served as the comparison group. A replication group consisted of 235 RA patients.
RESULTS:
No significant differences in baseline disease activity were observed between patients with high and those with moderate ACPA levels. However, the HLA-DRB1*15 allele was associated with high ACPA levels (P=0.0002). A similar trend was detected in HLA-DRB1*15-positive patients in the replication cohort, with meta-analysis of the discovery and replication cohorts demonstrating an overall effect of HLA-DRB1*15 on development of high ACPA levels in both the discovery and replication cohorts (P<0.0001 by Mantel-Haenszel test with a fixed-effects model).
CONCLUSION:
Our data indicate that HLA-DRB1*15 may promote the production of high ACPA levels. Due to the high value of ACPA level scores in the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for RA, the presence of HLA-DRB1*15 may, at least in part, contribute to fulfilling the criteria for RA. This illustrates the complex nature of the genetic regulation of ACPA levels. Additional mechanistic studies of the regulation of ACPAs and ACPA-positive RA are pending.
AuthorsJudit Laki, Emeli Lundström, Omri Snir, Johan Rönnelid, Izabella Ganji, Anca I Catrina, Camilla Bengtsson, Saedis Saevarsdottir, Marius C Wick, Lars Alfredsson, Lars Klareskog, Leonid Padyukov
JournalArthritis and rheumatism (Arthritis Rheum) Vol. 64 Issue 7 Pg. 2078-84 (Jul 2012) ISSN: 1529-0131 [Electronic] United States
PMID22307773 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 by the American College of Rheumatology.
Chemical References
  • Antibodies, Anti-Idiotypic
  • Epitopes
  • HLA-DRB1 Chains
  • HLA-DRB1*15 antigen
  • Peptides, Cyclic
Topics
  • Adult
  • Alleles
  • Antibodies, Anti-Idiotypic (blood, genetics)
  • Arthritis, Rheumatoid (blood, genetics, immunology)
  • Epitopes (genetics, immunology)
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • HLA-DRB1 Chains (genetics)
  • Humans
  • Male
  • Middle Aged
  • Peptides, Cyclic (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: